About Us
News
Products
Technolongy Platform
Investors
Contact Us
中文
EN
NEWS
Business Milestones
Patents
ALL
無列表圖
Business Milestones
11.17
2024
TAHO Pharmaceuticals Initiates U.S. Phase III Clinical Trial of TAH3311 Antithrombotic Oral Dissolving Film, Dosing First Subjects
無列表圖
Business Milestones
11.20
2019
TAHO's pediatric ADHD Oral Liquid granted exclusive U.S. sales rights to Hyloris
無列表圖
Business Milestones
08.16
2017
TAHO obtained approval for TAH4411 in Japan, a first anti-emetic oral dissolving film for chemotherapy in Japan.
中文
EN
About Us
News
Products
Technolongy Platform
Investors
Contact Us
ADD
3F., No. 550, Ruiguang Road, Neihu District, Taipei, 11492, Taiwan
TEL
+886-2-2659-8515
MAIL
info@tahopharma.com
© 2023 TAHO Pharmaceuticals Ltd. All rights reserved.
Design ibest
Verification
Click the numbers in sequence.
Change
